Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2021 16:05 ET | Source: Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results

Successfully completed multiple ascending dose (MAD) portion of a Phase 1 clinical trial for LP352, a potential treatment for seizures associated with a broad range of severe epilepsiesInitiating a...